Back to Search
HOWARD FINGERT, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1255470159Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
74510(MA)
Research & Publications (8)
Assessing proarrhythmic potential of drugs when optimal studies are infeasible.
PMID 19376308·Am Heart J·2009
6-review
Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development.
PMID 18024014·Eur J Cancer·2008
6-review
Brain natriuretic peptide: potential adjunct for cardiac risk assessment and management during treatment with experimental anticancer agents.
PMID 18989790·AAPS J·2007
5-case
Safety biomarkers and the clinical development of oncology therapeutics: considerations for cardiovascular safety and risk management.
PMID 16584137·AAPS J·2006
4-observational
Cardiac safety, risk management, and oncology drug development.
PMID 16778090·Clin Cancer Res·2006
8-other
Consideration of QT/QTc interval data in a phase I study in patients with advanced cancer.
PMID 15355930·Clin Cancer Res·2004
8-other
A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer.
PMID 15297406·Clin Cancer Res·2004
3-trial
Baseline heart rate-corrected QT and eligibility for clinical trials in oncology.
PMID 12947082·J Clin Oncol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 115 WABAN HILL RD N
CHESTNUT HILL, MA 02467 - Phone
- (860) 732-2776
Quick Facts
- NPI
- 1255470159
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile